Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for ...

Iopofosine I-131 achieved an overall response rate of 83.6% and a major response rate of 61.8% in patients with relapsed or ...

In May 2026, the U.S. defense landscape is undergoing a critical shift: the F-35 Lightning II, once the cornerstone of American air superiority, is grappling with severe Block 4 upgrade delays that ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from long-term global ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 11:40 AM EDTCompany ParticipantsMatthew Klein - CEO ...

Carl Zeiss Meditec AG ( CZMWY) Q2 2026 Earnings Call May 12, 2026 3:30 AM EDT ...

Operator: Greetings, and welcome to the PDS Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] It ...

Papzimias: A first-in-class FDA-approved gene therapy indicated for adult patients with recurrent respiratory papillomatosis (RRP), based on a proprietary adenovector technology platform. AdenoVerse ...

UCI’s Paul Merage School of Business is reducing tuition for two of its MBA programs by up to $38% in response to growing ...

Solving Canada's housing crisis requires immediate action to bring down costs. To provide Canadians with increased access to affordable and sustainable housing, the Government of Canada and the ...

Thank you for joining us in our third quarter earnings release this morning we not only reiterated our expectation of a near term resurgence of growth, but we also increased our outlook. I'm going to ...